Modeling immune system control of atherogenesis

Bioinformatics

Volumn 24, Issue 15, 2008, Pages 1715-1721

  Pappalardo, Francesco ^a   Musumeci, Salvatore ^b   Motta, Santo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ANTIBODY PRODUCTION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; B LYMPHOCYTE; CELLULAR IMMUNITY; COMPUTER MODEL; FOAM CELL; HELPER CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; LIPID OXIDATION; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; VIRTUAL REALITY;

ANIMALIA;

EID: 48249141403     PISSN: 13674803     EISSN: 13674811     Source Type: Journal    
DOI: 10.1093/bioinformatics/btn306     Document Type: Article

References (29)

1. Abbas,A.K. et al. (2007) Cellular and molecular immunology. 6th edn. Philadelphia, USA, Saunders.
2. Ameli,S. et al. (1996) Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Thromb. Vasc. Biol., 16, 1074-1079.
3. Artieda,M. et al. (2003) Serum chitotriosidase activity is increased in subjects with atherosclerosis disease. Arterioscler. Thromb. Vasc. Biol., 23, 1645-1652.
4. Artieda,M. et al. (2007) Serum chitotriosidase activity, a marker of activated macrophages, predicts new cardiovascular events independently of C-Reactive Protein. Cardiology, 108, 297-306.
5. Berliner,J.A. and Heinecke,J.W. (1996) The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med., 20, 707-727.
6. Binder,C.J. et al. (2002) Innate and acquired immunity in atherogenesis. Nat. Med., 8, 1218-1226.
7. Brizzi,P. et al. (2002) Oxidized LDL antibodies (OLAB) in patients with betathalassemia major. J. Atheroscler. Thromb., 9, 139-144.
8. Brizzi,P. et al. (2003) Plasma lipid composition and LDL oxidation. Clin. Chem. Lab. Med., 41, 56-60.
9. Brizzi,P. et al. (2004) Autoantibodies against oxidized low-density lipoprotein(ox-LDL) and LDL oxidation status. Clin. Chem. Lab. Med., 42, 164-170.
10. Celada,F. and Seiden,P.E. (1996) Affinity maturation and hypermutation in a simulation of the humoral immune response. Eur. J. Immunol., 26, 1350.
11. Cobbold,C.A. et al. (2002) Lipoprotein oxidation and its signicance for atherosclerosis: A mathematical approach. B. Math. Biol., 64, 65-95.
12. Daugherty,A. and Rateri,D.L. (2002) T lymphocytes in Atherosclerosis. The Yin-Yang of Th1 and Th2 influence on lesion formation. Circ. Res. 90, 1039-1040.
13. Farmer,J.D. et al. (1986) The immune system, adaption, and machine learning. Phisica D, 22, 187-204.
14. Goldsby,R.A. et al. (2000) In Austen,K.F. et al. (eds) Kuby Immunology. W.H. Freeman and Company, New York.
15. Ibragimov,A.I. et al. (2005) A mathematical model of atherogenesis as an inflammatory response. Math. Med. Biol., 22, 305-333.
16. Klimov,A.N. and Nikul'cheva,N.G. (1999) Lipid and Lipoprotein Metabolism and its Disturbances, Piter Kom, St. Petersburg.
17. Lollini,P.-L. et al. (2006) Discovery of cancer vaccination protocols with a genetic algorithm driving an agent based simulator. BMC Bioinformatics, 7, doi:10.1186/1471-2105-7-352.
18. Motta,S. et al. (2005) Modelling vaccination schedules for a cancer immunoprevention vaccine. Immunome Res., 1, doi:10.1186/1745-7580-1-5.
19. Orem,C. et al. (2002) The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: Relationship with low-density lipoprotein oxidation and plasma total antioxidant status. Coron. Artery Dis., 13, 56-71.
20. Pappalardo,F. et al. (2005) Modeling and simulation of cancer immunoprevention vaccine. Bioinformatics, 21, 2891-2987.
21. Romero-Corral,A. et al. (2006) Update in prevention of atherosclerotic heart disease: Management of major cardiovascular risk factors. Rev. Invest. Clin., 58, 237-244.
22. Ross,R. (1999) Atherosclerosis-an inflammatory disease. N. Engl. J. Med., 340, 115-126.
23. Shaw,P.X. et al. (2001) Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo. Arterioscler. Thromb. Vasc. Biol. 21, 1333-1339.
24. Shoji,T. et al. (2000) Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis, 148, 171-177.
25. Steinberg,D. (1997) Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem., 272, 20963-20966.
26. Thorne,B.C. et al. (2007) Combining experiments with multi-cell agent-based modeling to study biological tissue patterning. Brief. Bioinform., 8, 245-257.
27. Tinahones,F.J. et al. (2002) Increased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general population. Metabolism, 51, 429-431.
28. Tinahones,F.J. et al. (2005) Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population. J. Lipid Res., 46, 452-457.
29. Vinereanu,D. (2006) Risk factors for atherosclerotic disease: Present and future. Herz, 31 (Suppl. 3), 5-24.